Page last updated: 2024-11-02

pentoxifylline and Deafness, Transitory

pentoxifylline has been researched along with Deafness, Transitory in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Low-frequency hearing impairment (LFHI) is mainly attributed to endolymphatic hydrops and has a great variety of possible outcomes."1.33Prognostic relevance of anamnestic and diagnostic parameters in low-frequency hearing impairment. ( Maier, W; Schipper, J, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maier, W1
Schipper, J1
Wissen, I1
Aziz, MY1
Hörmann, K1
Bernal Sprekelsen, M1

Trials

1 trial available for pentoxifylline and Deafness, Transitory

ArticleYear
[Experiences in therapy of acute labyrinthine deafness with low-molecular dextran, pentoxifyllin and nicotinic acid (author's transl)].
    Laryngologie, Rhinologie, Otologie, 1981, Volume: 60, Issue:7

    Topics: Adult; Audiometry; Clinical Trials as Topic; Dextrans; Drug Therapy, Combination; Female; Fructose;

1981

Other Studies

2 other studies available for pentoxifylline and Deafness, Transitory

ArticleYear
Prognostic relevance of anamnestic and diagnostic parameters in low-frequency hearing impairment.
    The Journal of laryngology and otology, 2006, Volume: 120, Issue:8

    Topics: Acetazolamide; Age Factors; Aged; Audiometry, Pure-Tone; Auditory Threshold; Diuretics; Electronysta

2006
[Rheological therapeutic effects in diseases of the inner ear].
    Anales otorrinolaringologicos ibero-americanos, 1990, Volume: 17, Issue:4

    Topics: Adult; Blood Viscosity; Cochlea; Dextrans; Drug Evaluation; Drug Therapy, Combination; Female; Heari

1990